NAPSR Final Test Questions and
Answers | Study Guide
‣ Rights of drug administration . Answer: right patient, right medication,
right does, right route of administration, and right time of delivery
‣ Injection routes . Answer: intramuscular, intrathecal, intravenous,
subcutaneous
‣ intramuscular . Answer: drugs given by direct injection into muscle
tissue
‣ intrathecal . Answer: needle is inserted between to vertebrea in the
lower spine an into space around the spinal cord
‣ intravenous . Answer: injected directly into the veins
‣ subcutaneous . Answer: needle inserted into the fatty tissue just
beneath the skin
‣ Bioavailablility . Answer: how quickly and how much of a drug
reaches its intended target site of action
,‣ Bioequivalent . Answer: when drugs contain not only the same active
ingredients but also produce virtually the same blood levels over time
‣ Therapeutic equivalence . Answer: production of the same medicinal
effects
‣ Areas of drug elimination and excretion . Answer: Lungs, breast milk,
sweat tears urine feces, bile, saliva, and exhaled air
‣ medication error . Answer: failure to administer drug in the correct
form
‣ Powders . Answer: a drug that is dried and ground into fine particles
‣ pills . Answer: a single dose unit of medicine made by mixing the
powdered drug with liquid such as syrup and rolling it into a round or
oval shape
‣ granules . Answer: a small pill usually accompanied usually
accompanied by many others encased within a gelatin capsule; quite
often releasing medication over time
‣ tablet . Answer: pharmaceutical preparation made by compressing the
powdered for of a drug and bulk filling material under high pressure;
commonly used for anti acids and antiflatulents
,‣ Capsules . Answer: medication dosage form in which the drug is
contained in an external shell; can be pulled apart for access to contents
‣ sustained release . Answer: several doses of a drug in special coatings
that dissolve at different rates
‣ Enteric Coating . Answer: dosage in special coating that doesn't digest
in the stomach; only starts to digest in the intestines
‣ caplets . Answer: shaped like a capsule but has the form of a tablet the
shape and file make swallowing easier
‣ gel caps . Answer: an oil based medication that is enclosed in soft
gelatin capsule
‣ Emulsion . Answer: two agents that cannot ordinarily be combined or
mixed
‣ otic drugs . Answer: control localized infections or inflammation and
require very low dosages to be effective
‣ Types of drug despensing . Answer: OTC and prescription
‣ Type A (Augmented) drug reaction . Answer: exaggeration of the
drug's therapeutic effects
, ‣ Type B (idiosyncratic) . Answer: results from mechanisms that are not
currently understood; largely unpredictable
‣ Type C (continuing or chronic) . Answer: These persist for a long time
‣ Type D delayed . Answer: these take some time to develop
‣ Type E end of use . Answer: These occur during drug withdrawal
‣ Risk Factors . Answer: Use of several drugs, age, Pregnancy and breast
feeding
‣ Excipients . Answer: inactive ingredients
‣ Parenteral . Answer: intravenous, intramuscular, subcutaneous
‣ Rectal . Answer: suppository
‣ Oral . Answer: tablet, capsule, liquid
‣ Transdermal . Answer: through the skin via creams or patches
‣ Binders . Answer: cement the active and inert components of tablets
Answers | Study Guide
‣ Rights of drug administration . Answer: right patient, right medication,
right does, right route of administration, and right time of delivery
‣ Injection routes . Answer: intramuscular, intrathecal, intravenous,
subcutaneous
‣ intramuscular . Answer: drugs given by direct injection into muscle
tissue
‣ intrathecal . Answer: needle is inserted between to vertebrea in the
lower spine an into space around the spinal cord
‣ intravenous . Answer: injected directly into the veins
‣ subcutaneous . Answer: needle inserted into the fatty tissue just
beneath the skin
‣ Bioavailablility . Answer: how quickly and how much of a drug
reaches its intended target site of action
,‣ Bioequivalent . Answer: when drugs contain not only the same active
ingredients but also produce virtually the same blood levels over time
‣ Therapeutic equivalence . Answer: production of the same medicinal
effects
‣ Areas of drug elimination and excretion . Answer: Lungs, breast milk,
sweat tears urine feces, bile, saliva, and exhaled air
‣ medication error . Answer: failure to administer drug in the correct
form
‣ Powders . Answer: a drug that is dried and ground into fine particles
‣ pills . Answer: a single dose unit of medicine made by mixing the
powdered drug with liquid such as syrup and rolling it into a round or
oval shape
‣ granules . Answer: a small pill usually accompanied usually
accompanied by many others encased within a gelatin capsule; quite
often releasing medication over time
‣ tablet . Answer: pharmaceutical preparation made by compressing the
powdered for of a drug and bulk filling material under high pressure;
commonly used for anti acids and antiflatulents
,‣ Capsules . Answer: medication dosage form in which the drug is
contained in an external shell; can be pulled apart for access to contents
‣ sustained release . Answer: several doses of a drug in special coatings
that dissolve at different rates
‣ Enteric Coating . Answer: dosage in special coating that doesn't digest
in the stomach; only starts to digest in the intestines
‣ caplets . Answer: shaped like a capsule but has the form of a tablet the
shape and file make swallowing easier
‣ gel caps . Answer: an oil based medication that is enclosed in soft
gelatin capsule
‣ Emulsion . Answer: two agents that cannot ordinarily be combined or
mixed
‣ otic drugs . Answer: control localized infections or inflammation and
require very low dosages to be effective
‣ Types of drug despensing . Answer: OTC and prescription
‣ Type A (Augmented) drug reaction . Answer: exaggeration of the
drug's therapeutic effects
, ‣ Type B (idiosyncratic) . Answer: results from mechanisms that are not
currently understood; largely unpredictable
‣ Type C (continuing or chronic) . Answer: These persist for a long time
‣ Type D delayed . Answer: these take some time to develop
‣ Type E end of use . Answer: These occur during drug withdrawal
‣ Risk Factors . Answer: Use of several drugs, age, Pregnancy and breast
feeding
‣ Excipients . Answer: inactive ingredients
‣ Parenteral . Answer: intravenous, intramuscular, subcutaneous
‣ Rectal . Answer: suppository
‣ Oral . Answer: tablet, capsule, liquid
‣ Transdermal . Answer: through the skin via creams or patches
‣ Binders . Answer: cement the active and inert components of tablets
